Co-infection with vaginal Ureaplasma urealyticum and Mycoplasma hominis increases adverse pregnancy outcomes in patients with preterm labor or preterm premature rupture of membranes

Journal of Maternal-Fetal and Neonatal Medicine

Volumn 27, Issue 4, 2014, Pages 333-337

  Kwak, Dong Wook ^a,b   Hwang, Han Sung ^c   Kwon, Ja Young ^d   Park, Yong Won ^d   Kim, Young Han ^d  

^a Cheil General Hospital   (South Korea)

^b Yonsei University   (South Korea)

^c Konkuk University School of Medicine   (South Korea)

^d Yonsei University College of Medicine   (South Korea)

Author keywords

Antibiotic susceptibility; Mycoplasma hominis; PPROM; Preterm labor; Ureaplasma urealyticum

Indexed keywords

AZITHROMYCIN; CIPROFLOXACIN; CLARITHROMYCIN; DOXYCYCLINE; ERYTHROMYCIN; JOSAMYCIN; OFLOXACIN; PRISTINAMYCIN; TETRACYCLINE;

ADULT; ANTIBIOTIC SENSITIVITY; APGAR SCORE; ARTICLE; BACTERIAL COLONIZATION; BACTERIUM CARRIER; BIRTH WEIGHT; CHORIOAMNIONITIS; FEMALE; GESTATIONAL AGE; HUMAN; MAJOR CLINICAL STUDY; MYCOPLASMA HOMINIS; NEWBORN INTENSIVE CARE; NONHUMAN; PREGNANCY OUTCOME; PREMATURE FETUS MEMBRANE RUPTURE; PREMATURE LABOR; PREVALENCE; PRIORITY JOURNAL; UREAPLASMA UREALYTICUM; VAGINA SMEAR; COINFECTION; HOSPITAL ADMISSION; ISOLATION AND PURIFICATION; MICROBIOLOGY; MYCOPLASMA INFECTIONS; NEWBORN; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PREMATURITY; STATISTICS AND NUMERICAL DATA; UREAPLASMA INFECTIONS; VAGINA;

ADULT; CHORIOAMNIONITIS; COINFECTION; FEMALE; FETAL MEMBRANES, PREMATURE RUPTURE; HUMANS; INFANT, NEWBORN; INTENSIVE CARE UNITS, NEONATAL; MYCOPLASMA HOMINIS; MYCOPLASMA INFECTIONS; OBSTETRIC LABOR, PREMATURE; PATIENT ADMISSION; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PREGNANCY OUTCOME; PREMATURE BIRTH; PREVALENCE; UREAPLASMA INFECTIONS; UREAPLASMA UREALYTICUM; VAGINA;

EID: 84892732155     PISSN: 14767058     EISSN: 14764954     Source Type: Journal    
DOI: 10.3109/14767058.2013.818124     Document Type: Article

References (27)

1. Kramer MS, Demissie K, Yang H, et al. The contribution of mild and moderate preterm birth to infant mortality. Fetal and Infant Health Study Group of the Canadian Perinatal Surveillance System. J Am Med Assoc 2000;284:843-9.
2. Berg TG, Philpot KL, Welsh MS, et al. Ureaplasma/Mycoplasmainfected amniotic fluid: pregnancy outcome in treated and nontreated patients. J Perinatol 1999;19:275-7.
3. Yoon BH, Romero R, Kim M, et al. Clinical implications of detection of Ureaplasma urealyticum in the amniotic cavity with the polymerase chain reaction. Am J Obstet Gynecol 2000;183:1130-7.
4. Witt A, Berger A, Gruber CJ, et al. Increased intrauterine frequency of Ureaplasma urealyticum in women with preterm labor and preterm premature rupture of the membranes and subsequent cesarean delivery. Am J Obstet Gynecol 2005;193:1663-9.
5. Kundsin RB, Leviton A, Allred EN, Poulin SA. Ureaplasma urealyticum infection of the placenta in pregnancies that ended prematurely. Obstet Gynecol 1996;87:122-7.
6. Cassell GH, Waites KB, Watson HL, et al. Ureaplasma urealyticum intrauterine infection: role in prematurity and disease in newborns. Clin Microbiol Rev 1993;6:69-87.
7. McDonald HM, O'Loughlin JA, Jolley P, et al. Prenatal microbiological risk factors associated with preterm birth. BJOG 1992;99: 190-6.
8. Kacerovsky M, Pavlovsky M, Tosner J. Preterm premature rupture of the membranes and genital mycoplasmas. Acta Medica (Hradec Kralove) 2009;52:117-20.
9. Abele-Horn M, Scholz M, Wolff C, Kolben M. High-density vaginal ureaplasma urealyticum colonization as a risk factor for chorioamnionitis and preterm delivery. Acta Obstet Gynecol Scand 2000;79:973-8.
10. Doubilet PM, Benson CB, Nadel AS, Ringer SA. Improved birth weight table for neonates developed from gestations dated by early ultrasonography. J Ultrasound Med 1997;16:241-9.
11. Kundsin RB, Driscoll SG, Monson RR, et al. Association of Ureaplasma urealyticum in the placenta with perinatal morbidity and mortality. N Engl J Med 1984;310:941-5.
12. Dammann O, Allred EN, Genest DR, et al. Antenatal mycoplasma infection, the fetal inflammatory response and cerebral white matter damage in very-low-birthweight infants. Paediatr Perinat Epidemiol 2003;17:49-57.
13. Carey JC, Blackwelder WC, Nugent RP, et al. Anteparturn cultures for Ureaplasma urealyticum are not predicting pregnancy outcome. Am J Obstet Gynecol 1991;164:728-33.
14. Clegg A, Passey M, Yoannes M, Michael A. High rates of genital Mycoplasma infection in the highlands of Papua New Guinea determined both by culture and by a commercial detection kit. J Clin Microbiol 1997;35:197-200.
15. Vonsée HJ, Stobberingh EE, Bouckaert PX, et al. Detection of Chlamydia trachomatis, Mycoplasma hominis and Ureaplasma urealyticum in pregnant Dutch women. Eur J Obstet Gynecol Reprod Biol 1989;32:149-56.
16. Lee SE, Romero R, Kim EC, Yoon BH. A high Nugent score but not a positive culture for genital mycoplasmas is a risk factor for spontaneous preterm birth. J Matern Fetal Neonatal Med 2009;22: 212-7.
17. Kim MJ, Choi MH, Seong WJ, et al. The detection rate of Ureaplasma urealyticum and Mycoplasma hominis in patients with impending preterm birth and mid-trimester cervical swab. Korean J Perinatol 2008;19:370-6.
18. Choi SJ, Park SD, Jang IH, et al. The prevalence of vaginal microorganisms in pregnant women with preterm labor and preterm birth. Ann Lab Med 2012;32:194-200.
19. Pattinson RC, van Zyl GJ. Infections and spontaneous preterm labour: is looking for specific organisms worthwhile? S Afr J Epidemiol Infect 1991;6:12-4.
20. McGregor JA, French JI, Parker R, et al. Prevention of premature birth by screening and treatment for genital tract infections: results of a prospective controlled evaluation. Am J Obstet Gynecol 1995; 173:157-67.
21. Romero P, Mazor M, Oyarzun E, et al. Is genital colonization with Mycoplasma hominis or Ureaplasma urealyticum associated with prematurity/low birth weight? Obstet Gynecol 1989;73:532-6.
22. Odendaal HJ, Popov I, Schoeman J, Grové D. Preterm labour-Is Mycoplasma hominis involved? S Afr Med J 2002;92:235-7.
23. Park JK, Shin JK, Choi WJ, et al. Mycoplasma Infection of Cervicovaginal Fluid in Women with Preterm Labor. Korean J Perinatol 2005;16:128-36.
24. Kechagia N, Bersimis S, Chatzipanagiotou S. Incidence and antimicrobial susceptibilities of genital mycoplasmas in outpatient women with clinical vaginitis in Athens, Greece. J Antimicrob Chemother 2008;62:122-5.
25. Vogel I, Thorsen P, Hogan VK, et al. The joint effect of vaginal Ureaplasma urealyticum and bacterial vaginosis on adverse pregnancy outcomes. Acta Obstet Gynecol Scand 2006;85:778-85.
26. Koh EH, Kim Sj, Kim IS, et al. Antimicrobial Susceptibilities of Ureaplasma urealyticum and Mycoplasma hominis in Pregnant Women. Korean J Clin Microbiol 2009;12:159-62.
27. Renaudin H, Bébéar C. Comparative in vitro activity of azithromycin, clarithromycin, erythromycin and lomefloxacin against Mycoplasma pneumoniae, Mycoplasma hominis and Ureaplasma urealyticum. Eur J Clin Microbiol Infect Dis 1990;9:838-41.